Medigen Vaccine Biologics (ROCO:6547) Dividends per Share: NT$0.00 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6547 Medigen Vaccine Biologics Corp ROCO:6547
69 GF Score
Price NT$46.50
GF Value NT$57.66
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medigen Vaccine Biologics Dividends per Share?

Medigen Vaccine Biologics ROCO:6547 -1.80% 69 Dividends per Share is NT$0.00 as of Mar. 2026. GuruFocus rates ROCO:6547 with a GF Score™ of 69/100 and a GF Value™ of NT$57.66 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Medigen Vaccine Biologics's dividends per share for the three months ended in Mar. 2026 was NT$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was NT$0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, Medigen Vaccine Biologics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Medigen Vaccine Biologics  (ROCO:6547) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Medigen Vaccine Biologics's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ -0.09
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medigen Vaccine Biologics Dividends per Share Related Terms

Medigen Vaccine Biologics Dividends per Share Historical Data

* Premium members only.

The historical data trend for Medigen Vaccine Biologics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medigen Vaccine Biologics Dividends per Share Chart

Medigen Vaccine Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medigen Vaccine Biologics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ROCO:6547 vs VRTX, REGN, RVMD: Dividends per Share Comparison

For the Biotechnology subindustry, Medigen Vaccine Biologics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigen Vaccine Biologics Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Vaccine Biologics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Medigen Vaccine Biologics's Dividend Yield % falls into.


ROCO:6547
69GF Score
Medigen Vaccine Biologics Corp ROCO:6547
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medigen Vaccine Biologics Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of NT$0.00 mean?
Medigen Vaccine Biologics (ROCO:6547) has a Dividends per Share of NT$0.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Medigen Vaccine Biologics and its competitors.
Is Medigen Vaccine Biologics' Dividends per Share too high?
Medigen Vaccine Biologics' current Dividends per Share is NT$0.00. Overall, Medigen Vaccine Biologics has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medigen Vaccine Biologics' Dividends per Share compare to VRTX and REGN?
Medigen Vaccine Biologics' Dividends per Share of NT$0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Biotechnology company?
A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Medigen Vaccine Biologics and its competitors. Medigen Vaccine Biologics's current Dividends per Share is NT$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medigen Vaccine Biologics stock overvalued right now?
Based on GuruFocus' analysis, Medigen Vaccine Biologics (ROCO:6547) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$57.66, compared to a current price of NT$46.50 — trading 19.4% below its estimated fair value. The current Dividends per Share is NT$0.00. Medigen Vaccine Biologics' overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Medigen Vaccine Biologics (ROCO:6547), the current Dividends per Share is NT$0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medigen Vaccine Biologics (ROCO:6547) Overvalued in 2026?

Based on GuruFocus' analysis, Medigen Vaccine Biologics stock appears to be undervalued. The current stock price of NT$46.50 is trading 19.4% below its estimated GF Value™ of NT$57.66. GuruFocus considers Medigen Vaccine Biologics to be Modestly Undervalued.

Key valuation signals for ROCO:6547:

  • Dividends per Share: NT$0.00
  • GF Value™: NT$57.66 vs. price of NT$46.50 (19.4% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medigen Vaccine Biologics Business Description

Address 302 No. 68, Shengyi 3rd Road, Hsinchu County, Zhubei, TWN, 30261
Medigen Vaccine Biologics Corp is engaged in the research, development and wholesale of vaccine and biopharmaceutical, medical devices wholesale and retail, etc. Its products include dengue vaccine, anti-RSV biosimilars, COVID-19 vaccines, enterovirus A71 vaccine, and influenza vaccine QIZ. It operates business only in a single industry in Taiwan.
69GF Score

Get the complete analysis for ROCO:6547

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$46.50
Price
NT$57.66
GF Value